Steroid 17-Hydroxyprogesterone in Hair as a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

November 2019 in “ Neuroendocrinology ”

Matthias K. Auer, Aniko Krumbholz, Martin Bidlingmaier, Detlef Thieme, Nicole Reisch

17-hydroxyprogesterone 17-OHP congenital adrenal hyperplasia CAH 21-hydroxylase deficiency androgen control hyperandrogenism testosterone androstenedione hair cortisol adrenal androgen markers

TLDR Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

This study demonstrated that measuring 17-hydroxyprogesterone (17-OHP) concentrations in scalp hair could serve as a promising noninvasive long-term biomarker for monitoring androgen control in adults with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The study included 27 women and 15 men with CAH, along with 37 women and 42 men as controls. Significant correlations were found between hair and serum 17-OHP levels in both CAH men and women, and between hair and serum testosterone levels in CAH men. A cutoff value of 21.7 pg/mg for hair 17-OHP provided high sensitivity and specificity for identifying men with elevated serum androstenedione. For CAH women, a cutoff value of 27.6 pg/mg for hair 17-OHP was effective in identifying significant hyperandrogenism. However, hair cortisol and other adrenal androgen markers did not show significant associations with cardiometabolic outcomes or bone health.

View this study on karger.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Scalp Hair 17-Hydroxyprogesterone And Androstenedione As A Long-Term Therapy Monitoring Tool In Congenital Adrenal Hyperplasia

9 citations, April 2016 in “Clinical Endocrinology”

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia Among Women Presenting with Hyperandrogenic Symptoms and Signs

research A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia Among Women Presenting with Hyperandrogenic Symptoms and Signs

150 citations, November 2007 in “The Journal of Clinical Endocrinology and Metabolism”

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Similar Research

6 / 1000+ results

research Congenital Adrenal Hyperplasia: A Comprehensive Review

88 citations, April 2017 in “Journal of Pediatric and Adolescent Gynecology”

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

research Menstrual Disorders in Adolescents

75 citations, June 1999 in “Pediatric Clinics of North America”

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

research An Update on Congenital Adrenal Hyperplasia

151 citations, December 2004 in “Annals of the New York Academy of Sciences”

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

research Recommendations for Treatment of Nonclassic Congenital Adrenal Hyperplasia: An Update

56 citations, December 2011 in “Steroids”

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

research Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia

9 citations, February 2019 in “Journal of Clinical Research in Pediatric Endocrinology”

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

research Clinical Case Seminar: Postmenopausal Androgen Excess - Challenges in Diagnostic Work-Up and Management of Ovarian Thecosis

20 citations, October 2017 in “Clinical Endocrinology”

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Steroid 17-Hydroxyprogesterone in Hair as a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Research cited in this study

research Scalp Hair 17-Hydroxyprogesterone And Androstenedione As A Long-Term Therapy Monitoring Tool In Congenital Adrenal Hyperplasia

research A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia Among Women Presenting with Hyperandrogenic Symptoms and Signs

Related Community Posts Join

community 17-alpha-estradiol/Alfatradiol how does it Work for Hair loss?

community 17 M Hair loss, can Vitamin D and Seborrheic Dermatitis be the reasons?

community 17-Month Update - Dut, Min, Niz, 1.5mm roller.

community 17 month update 30M FUT 2300 grafts 1 year fin/min topical

community 17 years fighting hair loss. My story

community 17 month update, topical minoxidil + oral finasteride for the first 12 months, moved to topical last 5, + inconsistent 0.3mm microneedling before application for 4 months – more info in comments